Synedica Retatrutide 40mg Pen Kit: What’s Inside & Why It Matters

Synedica retatrutide injection pen kit: What’s Inside & Why It Matters

Everything you need to know about the most complete retatrutide injection kit available contents, dose settings, needle specifications, storage, and how to get started.

Order Your Kit →

What’s in the Synedica Retatrutide Kit

The Synedica Retatrutide 40mg Injection Pen Kit is designed to give you everything you need from day one — no sourcing needles separately, no deciphering generic instructions. Here’s exactly what arrives in your order:

💉
1 × Prefilled Pen
40mg retatrutide · Multi-dose dial · Adjustable 2.5–10mg increments
🪡
12 × Needles
Disposable 32 gauge · 4mm length · One per injection
📖
Instruction Booklet
Full protocol · Dosage schedule · Side effect guide · Storage instructions

The instruction booklet is not an afterthought — it contains the full Synedica dosage escalation protocol, injection technique guidance, a week-by-week titration chart, and a complete list of side effects to monitor. Everything a new user needs is packaged together. No clinic appointment required to begin.

40mg
Total retatrutide per pen
12
Disposable 32g 4mm needles included
~12 wks
Duration for average new user
4
Dose increment settings (2.5/5/7.5/10mg)

Pen Specifications & Dose Settings

The Synedica pen is a multi-dose, dial-controlled injection device. Unlike single-use auto-injectors, the pen allows you to set your precise dose at each stage of the protocol — critical for the step-wise escalation that makes retatrutide tolerable and effective.

The dial rotates to four dose settings:

2.5mg
Weeks 1–4 · Initiation
16 doses per pen
5mg
Weeks 5–8 · First escalation
8 doses per pen
7.5mg
Week 9+ · Second escalation
5 doses per pen
10mg
Week 13+ · Maximum
4 doses per pen

For the standard new-user protocol — 2.5mg for 4 weeks, then 5mg for weeks 5–8 — one 40mg pen covers approximately 12 weeks of treatment (4 doses at 2.5mg = 10mg used, then 4 doses at 5mg = 20mg used, leaving 10mg for an additional 4 weeks at 2.5mg or 2 weeks at 5mg). The exact duration depends on your escalation pace and whether you hold at any dose stage for additional weeks.

📋 The instruction booklet includes a dose tracking page so you can record each injection date, dose, and any side effects. This is particularly useful for your first 8 weeks when escalation is active.

The 32g 4mm Needle: Why It Matters

The 12 included needles are not generic. They are 32-gauge, 4mm — the specific needle gauge and length recommended for subcutaneous GLP-1 injection in adults of all body types.

Here’s why those numbers matter:

  • 32 gauge (thinner than 31g or 30g): A higher gauge number means a thinner needle. At 32g, the needle is narrow enough that most users report the injection as virtually painless. For reference, standard blood draw needles are 21–23g — significantly thicker.
  • 4mm length: Specifically designed to reach subcutaneous tissue (just under the skin) in adults without hitting muscle or going too shallow. At 4mm, you do not need to pinch the skin or change technique based on body composition — the length is appropriate across a wide range of injection sites and body types.
  • Single-use design: Each needle is sterile, single-use, and should be discarded after each injection. Reusing needles increases infection risk and dulls the tip, making injections more uncomfortable.

🪡 12 needles = 12 weekly injections. At the standard new-user escalation protocol (one injection per week), your 12 included needles cover exactly the 12-week initiation and first escalation period. If you require additional needles beyond week 12, you can source compatible 32g 4mm pen needles from most pharmacies or order them alongside your next Synedica pen kit.

How Many Doses Per Pen — Planning Your Supply

One of the most common questions we receive is how long one pen lasts. The answer depends entirely on which dose you’re on. Here’s the practical breakdown:

Dose Setting mg Used Per Injection Injections Per Pen Weeks of Treatment
2.5mg only 2.5mg 16 16 weeks
Standard new-user (2.5 → 5mg) Mixed ~12 ~12 weeks
5mg only 5mg 8 8 weeks
7.5mg only 7.5mg 5 5 weeks
10mg only 10mg 4 4 weeks

For users progressing through the full escalation protocol (2.5mg → 5mg → 7.5mg → 10mg), we recommend planning your supply at least 2 weeks ahead of your anticipated dose increase. This ensures there is no gap in your weekly injection schedule, which can temporarily reduce drug blood levels and interrupt the metabolic effect.

🛒 Wholesale buyers and clinics: if you are purchasing on behalf of a clinic or multiple patients, the Synedica wholesale programme provides volume pricing on all pen kits including retatrutide, tirzepatide and semaglutide.

The Two Pen Designs — Explained

You may have noticed references to two different Synedica Retatrutide pen designs. This is not a product inconsistency — it is a supply chain reality driven by unprecedented global demand.

Due to worldwide demand for Synedica products, Synedica currently works with multiple production facilities. Both facilities produce the Retatrutide 40mg pen to the same specification and quality standard. The physical appearance of the device may differ slightly between batches — button position, grip texture, label design — but the formulation, potency, and dose settings are identical.

⚠️ Counterfeit warning: A factory has been identified producing dangerous counterfeit Synedica pens. If your pen does not arrive via synedica-uk.shop directly, has no instruction booklet, or the dial mechanism feels inconsistent with this description, do not use it and contact Synedica immediately. Always purchase from the official Synedica website to guarantee authenticity.

Pen vs Vial: Why the Pen Format Wins

Some retatrutide suppliers offer the compound in lyophilised (freeze-dried) vial format requiring reconstitution with bacteriostatic water before injection. The Synedica pen eliminates all of this complexity.

Feature Vial + Syringe Synedica Pen Kit
Reconstitution required Yes — mix powder with water No — prefilled and ready
Dosing accuracy Manual — error-prone Dial-controlled — precise every time
Equipment needed Vials, syringes, water, alcohol swabs Just the included needles
Contamination risk Higher — multiple transfers Lower — sealed system
Instruction documentation Usually absent Full booklet included
Needle quality Varies by supplier 32g 4mm medical grade included

For users managing their own protocol outside a clinical trial setting, the pen format reduces friction, reduces error, and reduces contamination risk at every step. The Synedica pen is ready to use from the moment it arrives.

Frequently Asked Questions

Does the Synedica Retatrutide kit come with everything I need to start?

Yes. The kit includes the prefilled 40mg pen, 12 disposable 32g 4mm needles, and a complete instruction booklet covering dosage schedule, injection technique, storage guidance, and side effect information. No additional equipment is required to begin.

How do I set the dose on the pen?

The pen has a dial mechanism that rotates to four settings: 2.5mg, 5mg, 7.5mg, and 10mg. Turn the dial to your prescribed dose before each injection. The instruction booklet provides illustrated step-by-step guidance. Always confirm your dose setting before pressing the injection button.

Can I get a second pen before my first one runs out?

Yes — and we recommend it. Having your next pen ready before you need it ensures no gap in your weekly injection schedule. You can order additional kits directly at synedica-uk.shop, with free shipping on every order.

What if I receive a different pen design than shown?

Both Synedica pen designs contain exactly the same formulation at the same quality standard. If your pen arrives via synedica-uk.shop with the instruction booklet included, you have a genuine Synedica product regardless of which physical design you receive.

Order Your Synedica Retatrutide Kit

Free shipping · 40mg prefilled pen · 12 needles · Full instruction booklet included.

References

  1. Synedica UK. Synedica Retatrutide 40mg Injection Pen Kit — product page. synedica-uk.shop
  2. Jastreboff et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2. NEJM, 2023.
  3. Eli Lilly. TRIUMPH-1 Phase 3 Results. May 2026. prnewswire.com

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!